News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Louise M. Dube, PhD

Articles by Louise M. Dube, PhD

Safety and Clinical Efficacy of Zileuton in Patients with Chronic Asthma

ByStephen C. Lazarus, MD,Theodore Lee, MD,James P. Kemp, MD,Sally Wenzel, MD,Louise M. Dube, PhD,Rachel F. Ochs, MD, JD,Pierre J. Carpentier, MD,James F. Lancaster, PhD,the Zileuton Study Group

June 1st 1998

Randomized Trial of Zileuton in Patients with Moderate Asthma: Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms

ByLawrence M. DuBuske, MD,Jay Grossman, MD,Louise M. Dube, PhD,Linda J. Swanson, PhD,James F. Lancaster, PhD,the Zileuton Study Group

April 1st 1997

Latest Updated Articles

Safety and Clinical Efficacy of Zileuton in Patients with Chronic Asthma
Published: June 1st 1998 | Updated:
Randomized Trial of Zileuton in Patients with Moderate Asthma: Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms
Published: April 1st 1997 | Updated:

Trending on AJMC

Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers

Patients Face New Care Complexities as DTC Options Expand

FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer

Louisiana Delivers Innovative Cancer Treatments, but Ensuring Access Is a Work in Progress

FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.